Pacific Biosciences of California, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was USD 30.610 million compared to USD 17.077 million a year ago. Operating loss was USD 37.573 million compared to USD 23.524 million a year ago. Net loss was USD 41.001 million compared to USD 23.086 million a year ago. Basic loss per share from continuing operations was USD 0.21 compared to USD 0.15 a year ago. For the half year, total revenue was USD 59.607 million compared to USD 32.675 million a year ago. Operating loss was USD 71.283 million compared to USD 56.233 million a year ago. Net loss was USD 128.436 million compared to USD 21.824 million a year ago. Basic loss per share from continuing operations was USD 0.65 compared to USD 0.14 a year ago.